Advanced
Product
Solutions
Partners
Resources
Company
Toggle menu
Home
/
Berry Genomics
Berry Genomics
Overview
Locations
Financials
Operating Metrics
Human Capital
Key People
Competitors
Supplier Risk
Berry Genomics
Stock Price
¥9.6
2024-10-29
Market Capitalization
¥3.3 B
2024-10-29
Revenue
¥1 B
FY, 2024
Berry Genomics Summary
Company Summary
Overview
Berry Genomics (贝瑞基因) is a biotechnology company that develops sequencing-based integrated solutions for life sciences and clinical applications. The company focuses on genetic testing and oncology testing.
Type
Public
Status
Active
Founded
2010
HQ
CN
|
view all locations
Website
https://www.berrygenomics.com/
Cybersecurity rating
ESG rating
30-39 out of 100
|
View all ESG data
Sectors
Healthcare
biotech
genetics
medical devices
oncology
Homepage
Linkedin
Table of Contents
Locations
Financials
Competitors
Locations
View all
1 location detected
Beijing Shi
HQ
China
Berry Genomics Financials
Summary Financials
Revenue (Q3, 2025)
¥242.4M
Gross profit (Q3, 2025)
¥104.6M
Net income (Q3, 2025)
(¥25.0M)
Cash (Q3, 2025)
¥309.7M
EBIT (Q3, 2025)
(¥23.4M)
Enterprise value
$3.3B
Competitors and Similar Companies
ZAI Lab
Healthcare - Public
GenomePrecision
Healthcare - Private
BioChain
Healthcare - Subsidiary
SEASUN BIOMATERIALS
Healthcare - Private
Compare competitors
Footer menu
Contact us
Product
Intelligence Suite
Supplier Intelligence Platform
Craft Intelligence Portal
Craft API
Craft for Teams
Supplier Intelligence Platform
Craft Alerts
Craft N-Tier Mapping
Craft Risk Hub
Chrome extension
Solutions
Supplier Intelligence
Sales Intelligence
Aerospace and Defense
Resources
Resource center
Blog
Company
About
Careers
Contact
Terms of Service
Privacy Policy
Security
© Craft.co 2026
Share price data provided by IEX
Back
to top